WO2014063111A8 - Drug delivery medical device - Google Patents

Drug delivery medical device Download PDF

Info

Publication number
WO2014063111A8
WO2014063111A8 PCT/US2013/065777 US2013065777W WO2014063111A8 WO 2014063111 A8 WO2014063111 A8 WO 2014063111A8 US 2013065777 W US2013065777 W US 2013065777W WO 2014063111 A8 WO2014063111 A8 WO 2014063111A8
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
pharmaceutical agent
medical device
coating
drug delivery
Prior art date
Application number
PCT/US2013/065777
Other languages
French (fr)
Other versions
WO2014063111A1 (en
Inventor
James B. Mcclain
Charles Douglas Taylor
Meagan M. FAGAN
Original Assignee
Micell Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micell Technologies, Inc. filed Critical Micell Technologies, Inc.
Priority to EP13847009.1A priority Critical patent/EP2908874A4/en
Priority to US14/437,097 priority patent/US10188772B2/en
Priority to JP2015538086A priority patent/JP2015533305A/en
Priority to CN201380066590.1A priority patent/CN104994891A/en
Priority to CA2888776A priority patent/CA2888776C/en
Priority to AU2013331003A priority patent/AU2013331003B2/en
Publication of WO2014063111A1 publication Critical patent/WO2014063111A1/en
Publication of WO2014063111A8 publication Critical patent/WO2014063111A8/en
Priority to HK16101611.9A priority patent/HK1213503A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/63—Crystals

Abstract

A medical device that releases a pharmaceutical agent to a target site is disclosed. The medical device includes a balloon, and a coating on at least a portion of the balloon. The coating includes particles of a pharmaceutical agent. Each particle of the particles of the pharmaceutical agent is at least partially encapsulated in a polymer material. A method of releasing a pharmaceutical agent at a target site is also disclosed. The method includes the steps of providing a device including a balloon, and a coating on at least a portion of the balloon, the coating including particles of a pharmaceutical agent, and each particle of the pharmaceutical agent is at least partially encapsulated in a polymer material; positioning the device to allow the balloon to reach the target site; and inflating the balloon of the device.
PCT/US2013/065777 2011-10-18 2013-10-18 Drug delivery medical device WO2014063111A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP13847009.1A EP2908874A4 (en) 2012-10-18 2013-10-18 Drug delivery medical device
US14/437,097 US10188772B2 (en) 2011-10-18 2013-10-18 Drug delivery medical device
JP2015538086A JP2015533305A (en) 2012-10-18 2013-10-18 Drug delivery medical device
CN201380066590.1A CN104994891A (en) 2012-10-18 2013-10-18 Drug delivery medical device
CA2888776A CA2888776C (en) 2012-10-18 2013-10-18 Drug delivery medical device
AU2013331003A AU2013331003B2 (en) 2012-10-18 2013-10-18 Drug delivery medical device
HK16101611.9A HK1213503A1 (en) 2012-10-18 2016-02-15 Drug delivery medical device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261715768P 2012-10-18 2012-10-18
US61/715,768 2012-10-18

Publications (2)

Publication Number Publication Date
WO2014063111A1 WO2014063111A1 (en) 2014-04-24
WO2014063111A8 true WO2014063111A8 (en) 2014-05-30

Family

ID=50488802

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/065777 WO2014063111A1 (en) 2011-10-18 2013-10-18 Drug delivery medical device

Country Status (7)

Country Link
EP (1) EP2908874A4 (en)
JP (1) JP2015533305A (en)
CN (2) CN104994891A (en)
AU (1) AU2013331003B2 (en)
CA (1) CA2888776C (en)
HK (1) HK1213503A1 (en)
WO (1) WO2014063111A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
EP2019657B1 (en) 2006-04-26 2015-05-27 Micell Technologies, Inc. Coatings containing multiple drugs
US9539593B2 (en) 2006-10-23 2017-01-10 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
EP2111184B1 (en) 2007-01-08 2018-07-25 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CA2688314C (en) 2007-05-25 2013-12-03 Micell Technologies, Inc. Polymer films for medical device coating
MX350637B (en) 2008-04-17 2017-09-11 Micell Technologies Inc Stents having bioabsorbable layers.
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
WO2010009335A1 (en) 2008-07-17 2010-01-21 Micell Technologies, Inc. Drug delivery medical device
CN102481195B (en) 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
CA2759015C (en) 2009-04-17 2017-06-20 James B. Mcclain Stents having controlled elution
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
US20130172853A1 (en) 2010-07-16 2013-07-04 Micell Technologies, Inc. Drug delivery medical device
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CN110269959A (en) 2013-03-12 2019-09-24 脉胜医疗技术公司 Bioabsorbable biomedical implants
US10272606B2 (en) 2013-05-15 2019-04-30 Micell Technologies, Inc. Bioabsorbable biomedical implants
CN105031741A (en) * 2015-03-03 2015-11-11 江苏海泽医疗科技发展有限公司 Medical catheter with anti-infective drug coating and drug slowly-releasing function and preparing method thereof
KR20200074963A (en) * 2017-10-18 2020-06-25 비브이더블유 홀딩 에이쥐 Devices with microstructure-mediated adsorption profiles
JP7315658B2 (en) * 2018-08-01 2023-07-26 ボストン サイエンティフィック サイムド，インコーポレイテッド Drug release coating composition
CN113616857B (en) * 2021-08-27 2022-05-31 谱高医疗科技(南京)有限公司 Preparation method of rapamycin drug balloon and rapamycin drug balloon

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055710A1 (en) * 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US7682656B2 (en) * 2004-06-14 2010-03-23 Agruim Inc. Process and apparatus for producing a coated product
US7842312B2 (en) * 2005-12-29 2010-11-30 Cordis Corporation Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
JP4297221B2 (en) * 2006-02-15 2009-07-15 株式会社ホソカワ粉体技術研究所 Method for producing drug-eluting stent
US20080175887A1 (en) * 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
CA2743022C (en) * 2007-01-21 2012-10-09 Hemoteq Ag Methods for coating catheter balloons with a defined quantity of active agent
CN101161300B (en) * 2007-11-27 2011-03-16 北京美中双和医疗器械有限公司 Arsenic trioxide medicament elution bracket and its preparation method
CN101264347A (en) * 2007-11-27 2008-09-17 天津百畅医疗器械科技有限公司 Drug-eluting coated on surface of sacculus catheter air bag for alleviating vascular restenosis
WO2009096822A1 (en) * 2008-01-30 2009-08-06 Micromuscle Ab Drug delivery devices and methods and applications thereof
WO2009113605A1 (en) * 2008-03-12 2009-09-17 アンジェスＭｇ株式会社 Drug elution-type catheter and method for manufacturing the drug elution-type catheter
US8951545B2 (en) * 2008-03-28 2015-02-10 Surmodics, Inc. Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
WO2010024898A2 (en) * 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
CN102481195B (en) * 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
WO2010136604A1 (en) * 2009-05-29 2010-12-02 Dsm Ip Assets B.V. Transfer matrix for transferring a bioactive agent to body tissue
WO2011097103A1 (en) * 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US20130172853A1 (en) * 2010-07-16 2013-07-04 Micell Technologies, Inc. Drug delivery medical device
US9801831B2 (en) * 2010-12-30 2017-10-31 Nanyang Technological University Device for controlled release of a bioactive agent
US20120177742A1 (en) * 2010-12-30 2012-07-12 Micell Technologies, Inc. Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore

Also Published As

Publication number Publication date
AU2013331003A1 (en) 2015-05-07
WO2014063111A1 (en) 2014-04-24
HK1213503A1 (en) 2016-07-08
CA2888776A1 (en) 2014-04-24
CN110935070A (en) 2020-03-31
CN104994891A (en) 2015-10-21
JP2015533305A (en) 2015-11-24
AU2013331003B2 (en) 2016-11-24
CA2888776C (en) 2020-12-29
EP2908874A4 (en) 2016-06-22
EP2908874A1 (en) 2015-08-26

Similar Documents

Publication Publication Date Title
WO2014063111A8 (en) Drug delivery medical device
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
EP2605698A4 (en) Central site photoplethysmography, medication administration, and safety
WO2016004048A3 (en) Targeted conjugates and particles and formulations thereof
WO2017091749A8 (en) Shape changing drug delivery devices and methods
IL232308A (en) C0mpounds as modulators of atp-binding cassette transporters, pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating diseases and processes for preparation thereof
WO2012009684A3 (en) Drug delivery medical device
WO2015050814A3 (en) Therapeutic agents for delivery using a catheter and pressure source
MY172519A (en) Solid polymeric controlled release nanoparticle
TW201613562A (en) Formulation comprising particles
EP3065808A4 (en) Devices and methods for continuous drug delivery via the mouth
HK1205908A1 (en) Vascular occlusion and drug delivery devices, systems, and methods
WO2012035429A3 (en) Remotely controlled drug delivery systems
WO2011140274A3 (en) Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2008118861A3 (en) Discrete size and shape specific organic nanoparticles designed to elicit an immune response
MD20160079A2 (en) Drug delivery system
WO2011143201A3 (en) Ratiometric combinatorial drug delivery
EP2531234A4 (en) Low dose prefilled drug delivery device and method
WO2011139479A3 (en) High shear application in drug delivery
GB2482691B (en) Structures for transdermal drug delivery
IL224430B (en) Liquid pharmaceutical formulation comprising st-246 and a beta-cyclodextrin, a process of making the liquid formulation, a unit dosage liquid formulation and a process for preparing a water-soluble solid st-246 pharmaceutical formulation
WO2013114371A8 (en) Dry powder formulations of dnase i
WO2012091748A3 (en) Therapeutic agent reservoir delivery system
BR112012026465A2 (en) liquid pharmaceutical formulation, lyophilized particles, lyophilized particle preparation method and treatment method
WO2011146699A3 (en) Nanochanneled device and related methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13847009

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2888776

Country of ref document: CA

Ref document number: 2015538086

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 14437097

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2013331003

Country of ref document: AU

Date of ref document: 20131018

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2013847009

Country of ref document: EP